ReviewAnnals of the rheumatic diseases2016
The changing landscape of biosimilars in rheumatology.
Thomas Dörner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
79 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewAnnals of the rheumatic diseases2016
Thomas Dörner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.